HMMR and neoplasm: The receptor for hyaluronic acid-mediated motility (RHAMM) mediates both Ras and TGF-b signalling pathways and is associated with poor prognosis in a variety of tumour entities (Wang et al, 1998; Maxwell et al, 2004; Hamilton et al, 2007).